American Journal of Cardiology
Volume 103, Issue 8 , Pages 1061-1065 , 15 April 2009

Troponin I Rise After Pacemaker Implantation at the Time of “Universal Definition of Myocardial Infarction”

Received 26 September 2008 ,Revised 5 January 2009 ,Accepted 5 January 2009.

References 

  1. Williams EJ, Jones CJ, McDowell IF, Tovey JA, Thomas MA, Wayte AM, et al. Recommended standards for biochemical markers of myocardial damage: All Wales Clinical Biochemistry Audit Group. Ann Clin Biochem. 2005;42:346–350
  2. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem. 1999;45:1104–1121
  3. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525–2538
  4. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J. 2002;144:981–986
  5. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005;142:786–791
  6. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146–150
  7. Gunnewiek JM, Van Der Hoeven JG. Cardiac troponin elevations among critically ill patients. Curr Opin Crit Care. 2004;10:342–346
  8. Boos CJ, Gough S, Wheather M, Medbak S, More R. Effects of transvenous pacing on cardiac troponin release. Pacing Clin Electrophysiol. 2004;27:1264–1268
  9. Hurst TM, Hinrichs M, Breidenbach C, Katz N, Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter–defibrillators. J Am Coll Cardiol. 1999;34:402–408
  10. Nikolaou NI, Spanodimos SG, Tsaglis EP, Antonatos DG, Patsilinakos SP, Fournarakis GM, et al. Biochemical evidence of cardiac damage following transvenous implantation of a permanent antibradycardia pacemaker lead. Pacing Clin Electrophysiol. 2005;28:1174–1181
  11. Dworschak M, Franz M, Khazen C, Czerny M, Haisjackl M, Hiesmayr M. Mechanical trauma as the major cause of troponin T release after transvenous implantation of cardioverter/defibrillators. Cardiology. 2001;95:212–214
  12. Etievent JP, Chocron S, Toubin G, Taberlet C, Alwan K, Clement F, et al. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg. 1995;59:1192–1194
  13. Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J. 2003;146:446–452
  14. King DA, Codish S, Novack V, Barski L, Almog Y. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care. 2005;9(suppl):R390–R395
  15. Lim W, Cook DJ, Griffith LE, Crowther MA, Devereaux PJ. Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes. Am J Crit Care. 2006;15:280–289
  16. Lim W, Holinski P, Devereaux PJ, Tkaczyk A, McDonald E, Clarke F, et al. Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings. Crit Care. 2008;12(suppl):R36;Available at: http://ccforum.com/content/12/2/R36
  17. Turley AJ, Gedney JA. Role of cardiac troponin as a prognosticator in critically ill patients. Crit Care. 2005;9(suppl):E30
  18. Adabag AS, Rector T, Mithani S, Harmala J, Ward HB, Kelly RF, et al. Prognostic significance of elevated cardiac troponin I after heart surgery. Ann Thorac Surg. 2007;83:1744–1750
  19. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007;116:1242–1249
  20. Steen H, Futterer S, Merten C, Junger C, Katus HA, Giannitsis E. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. J Cardiovasc Magn Reson. 2007;9:749–758
  21. Baggish AL, MacGillivray TE, Hoffman W, Newell JB, Lewandrowski KB, Lee-Lewandrowski E, et al. Postoperative troponin-T predicts prolonged intensive care unit length of stay following cardiac surgery. Crit Care Med. 2004;32:1866–1871
  22. Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med. 2008;36:759–765

PII: S0002-9149(09)00039-3

doi: 10.1016/j.amjcard.2009.01.004

American Journal of Cardiology
Volume 103, Issue 8 , Pages 1061-1065 , 15 April 2009

Article Tools

* Image Usage & Resolution